Moderna advances combo vaccine for flu and COVID-19 with trials starting in March Pharmaceutical companies gear up to tackle ...
Stock-plunging mRNA vaccine maker, already in bed with feds on vaccine royalties, says booster not "causally" related without ...
The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...
Up to 21 million people contract norovirus each year in the U.S. alone, the CDC says. Though most people recover from the ...
Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.
CAMBRIDGE, MA / ACCESS Newswire / January 17, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S ...
Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) ...
Moderna (MRNA) announced ongoing support from the U.S. Department of Health and Human Services, HHS, to accelerate the development of ...
The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.
The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect against bird flu, the pharmaceutical company announced Friday.